December 2023 in “Revista Urología Colombiana / Colombian Urology Journal” More research is needed to find effective treatments for sickle cell disease-related priapism.
Hair cortisol may help identify adrenal insufficiency in sickle cell disease patients.
February 2026 in “The Journal of Sexual Medicine” A 34-year-old male with sickle cell disease experienced recurrent ischemic priapism, unresponsive to standard treatments, including oral etilefrine and bicalutamide. As a last resort before considering penile prosthesis, he was treated with goserelin, a gonadotropin-releasing hormone (GnRH) agonist, which resulted in significant clinical improvement, cessation of stuttering priapism, and recovery of erectile function. The patient opted to continue hormonal therapy, avoiding surgery. This case highlights the potential of GnRH agonists in managing recurrent priapism in sickle cell patients, though long-term safety remains uncertain and warrants further study.
April 2011 in “The Journal of Urology” Finasteride effectively reduced priapism episodes in children with sickle cell disease without side effects.
1 citations
,
July 2024 in “International Journal of Biological Research” Parental socioeconomic status doesn't improve dietary habits or reduce disease severity in children with sickle cell disease.